Exchange: OTC·Updated 09:57 AM EDT

GNTTF GeneTether Therapeutics Inc

$0.16
$0.1596
(39900.00%)
Today
Mkt Cap$12.12M
Vol5,000.00

About GNTTF

Rize Oncology, Inc. is a genetic medicines company, which engages in the creation of gene editing therapies based on the GeneTether platform. The company was founded by Daren Graham, William J. Garner, and R. Geoffrey Sargent on February 12, 2018 and is headquartered in Kelowna, Canada.
50

Sentiment

How do you feel about GNTTF?

Advertisement|Remove ads.